News
BCTXW
0.0009
-57.14%
-0.0012
Weekly Report: what happened at BCTX last week (0810-0814)?
Weekly Report · 16h ago
Weekly Report: what happened at BCTX last week (0803-0807)?
Weekly Report · 08/10 09:06
BriaCell Therapeutics Receives FDA Clearance To Proceed With Clinical Evaluation Of Bria-PROS+, Its Next-Gen Personalized Off-The-Shelf Immunotherapy For Prostate Cancer
Benzinga · 08/05 11:33
BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer
Barchart · 08/05 06:30
Weekly Report: what happened at BCTX last week (0727-0731)?
Weekly Report · 08/03 09:06
Weekly Report: what happened at BCTX last week (0720-0724)?
Weekly Report · 07/27 09:07
Weekly Report: what happened at BCTX last week (0713-0717)?
Weekly Report · 07/20 09:06
Source Rock Royalties Declares Monthly Dividend and Grants New RSUs
TipRanks · 07/16 11:51
BriaCell announces Odette Cancer Centre joins Bria-IMT trial
TipRanks · 07/16 11:40
Odette Cancer Centre At Sunnybrook Health Sciences Centre Joined BriaCell’s Ongoing Pivotal Phase 3 Study Of Bria-IMT Plus Immune Checkpoint Inhibitor In Metastatic Breast Cancer
Benzinga · 07/16 11:36
Stocks in play: BriaCell Therapeutics Corp.
Barchart · 07/16 08:53
BriaCell Therapeutics Enters Manufacturing Arrangement With FUJIFILM Biotechnologies To Support Phase 3 Clinical Development And Potential Future Commercial Supply Of Its Allogenic Cell Therapy BRIA-IMT
Benzinga · 07/15 11:35
BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™
Barchart · 07/15 06:30
Weekly Report: what happened at BCTX last week (0706-0710)?
Weekly Report · 07/13 09:07
BriaCell Therapeutics Engages Charles River Associates, Kaleio To Explore Commercial Strategy, Market Access Evaluation Of Bria-IMT
Benzinga · 07/07 11:32
BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™
Barchart · 07/07 06:30
Weekly Report: what happened at BCTX last week (0629-0703)?
Weekly Report · 07/06 09:07
Weekly Report: what happened at BCTX last week (0622-0626)?
Weekly Report · 06/29 09:06
BriaCell Subsidiary Highlights Interim Results, Ongoing Losses
TipRanks · 06/26 20:33
BriaCell Partners With Uneedle To Support Scalable Microneedle Delivery Of Bria-IMT
NASDAQ · 06/26 10:06
More
Webull provides a variety of real-time BCTXW stock news. You can receive the latest news about Briacell Therapeutics Corp through multiple platforms. This information may help you make smarter investment decisions.
About BCTXW
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops immunotherapies to transform cancer care. The Company’s lead drug candidate, Bria-IMT, is a cell-based patented immunotherapy that stimulates a patient’s own cancer fighting cells to attack and destroy breast cancer tumors. The Company is advancing its targeted immunotherapy program by prioritizing a Phase II clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor. The Company is focused on conducting a Phase I/IIa clinical trial of Bria-IMT in a combination study with Incyte’s immune PD-1 inhibitor, retifanlimab, in advanced breast cancer. The Company is also developing Bria-OTS, an off-the-shelf personalized approach to whole cell cancer immunotherapy. The Bria-OTS immunotherapy is based on a patient’s HLA-type. Its pipeline also includes Bria-Pros, Bria-Lung, Bria-Mel and sCD80, which are in development to treat various cancers.